Skip to main content
SpringerLink
Log in

Update on Intranasal Medications in Rhinosinusitis

  • Rhinosinusitis (J Mullol, Section Editor)
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

Abstract

This review describes beneficial effects and adverse events of various intranasal medications in treating rhinosinusitis. Application of intranasal steroids has been described in treating all subtypes of adult rhinosinusitis, but reports are limited in pediatrics and mostly in acute pediatric subgroups resulted in benefits While saline irrigation is effective for patients with chronic rhinosinusitis without polyps and in pediatric acute rhinosinusitis, there is no evidence yet for saline drips and sprays. Application of intranasal antifungals and nasal irrigation with surfactant brings more harm than benefits. There is no evidence supporting the use of intranasal antibiotics. We also review influence of devices, methods, and patient head position on nasal and paranasal sinus drug delivery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. •• Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinology Suppl. 2012;50(23):1–298. The European Position Paper on Rhinosinusitis and Nasal Polyps 2012 is the update of evidence based position papers with regard to rhinosinusitis and nasal polyps. Management schemes based on the evidence are analyzed, summarized and proposed.

    Google Scholar 

  2. Harvey RJ, Schlosser RJ. Local drug delivery. Otolaryngol Clin N am. 2009;42(5):829–45. ix

    Article  Google Scholar 

  3. • Lam M, Hull L, Imrie A, Snidvongs K, Chin D, Pratt E, et al. Interleukin-25 and interleukin-33 as mediators of eosinophilic inflammation in chronic rhinosinusitis. Am J Rhinol Allergy. 2015;29(3):175–81. Assessing sinus mucosal samples from 39 patients undergoing sinus surgery, this group demonstrated that epithelial-derived cytokines including IL-25 and IL-33 implicated in the initiation of T-helper 2 inflammation and eosinophilia in chronic rhinosinusitis. IL-25 and IL-33 overexpression was observed in eosinophilic inflammation.

    Article  PubMed  Google Scholar 

  4. Lee SH. Mechanisms of glucocorticoid action in chronic rhinosinusitis. Allergy Asthma Immunol Res. 2015;7(6):534–7.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mullol J, Obando A, Pujols L, Alobid I. Corticosteroids treatment in chronic rhinosinusitis: the possibilities and the limits. Immunol Allergy Clin N am. 2009;29(4):657–68.

    Article  Google Scholar 

  6. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005;116(6):1289–95.

    Article  CAS  PubMed  Google Scholar 

  7. Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology. 2007;45(3):190–6.

    PubMed  Google Scholar 

  8. Meltzer EO, Gates D, Bachert C. Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis. Ann Allergy Asthma Immunol. 2012;108(4):275–9.

    Article  CAS  PubMed  Google Scholar 

  9. Keith PK, Dymek A, Pfaar O, Fokkens W, Yun Kirby S, Wu W, et al. Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study. Prim Care Respir J. 2012;21(3):267–75.

    Article  PubMed  Google Scholar 

  10. Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, et al. Antibiotics and topical nasal steroids for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA. 2007;298(21):2487–96.

    Article  CAS  PubMed  Google Scholar 

  11. •• Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. The Cochrane Database Syst Rev. 2013;12:CD005149. A nice systematic review of the effects of intranasal steroids in relieving symptoms of acute rhinosinusitis in both adults and children. Evidence and recommendations regarding the use of intranasal steroids as a monotherapy and as an adjuvant therapy to antibiotics.

    Google Scholar 

  12. Barlan IB, Erkan E, Bakir M, Berrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotics therapy for acute sinusitis in children. Ann Allergy Asthma Immunol. 1997;78(6):598–601.

    Article  CAS  PubMed  Google Scholar 

  13. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW Jr, Califf RM, Simel DL, et al. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. Jama. 2001;286(24):3097–105.

    Article  CAS  PubMed  Google Scholar 

  14. Nayak AS, Settipane GA, Pedinoff A, Charous BL, Meltzer EO, Busse WW, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol. 2002;89(3):271–8.

    Article  CAS  PubMed  Google Scholar 

  15. Yilmaz G, Varan B, Yilmaz T, Gurakan B. Intranasal budesonide spray as an adjunct to oral antibiotics therapy for acute sinusitis in children. Eur Arch ORL. 2000;257(5):256–9.

    CAS  Google Scholar 

  16. Rahmati MB, Mohebi S, Shahmohammadi S, Rezai MS. Fluticasone nasal spray as an adjunct to amoxicillin for acute sinusitis in children: a randomized controlled trial. Eur Rev Med Pharmacol Sci. 2013;17(22):3068–72.

    CAS  PubMed  Google Scholar 

  17. Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ. Topical steroids for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev. 2011;8:CD009274.

    Google Scholar 

  18. •• Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011996. A systematic review of the effects of intranasal steroids in treating patients with chronic rhinosinusitis. The group included 18 randomized controlled trials with a total of 2738 participants including both nasal polyps and without nasal polyps. Meta-analyses for all symptoms were performed. Size of benefit was assessed.

    PubMed  Google Scholar 

  19. Hansen FS, Djupesland PG, Fokkens WJ. Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. Rhinology. 2010;48(3):292–9.

    CAS  PubMed  Google Scholar 

  20. Mosges R, Bachert C, Rudack C, Hauswald B, Klimek L, Spaeth J, et al. Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis. Adv Ther. 2011;28(3):238–49.

    Article  CAS  PubMed  Google Scholar 

  21. Parikh A, Scadding GK, Darby Y, Baker RC. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology. 2001;39(2):75–9.

    CAS  PubMed  Google Scholar 

  22. Kalish L, Snidvongs K, Sivasubramaniam R, Cope D, Harvey RJ. Topical steroids for nasal polyps. Cochrane Database Syst rev. 2012;12:CD006549.

    PubMed  Google Scholar 

  23. Chur V, Small CB, Stryszak P, Teper A. Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children. Pediatr Allergy Immunol. 2013;24(1):33–8.

    Article  PubMed  Google Scholar 

  24. Georgitis JW. Nasal hyperthermia and simple irrigation for perennial rhinitis. Changes in inflammatory mediators. Chest. 1994;106(5):1487–92.

    Article  CAS  PubMed  Google Scholar 

  25. Homer JJ, Dowley AC, Condon L, El-Jassar P, Sood S. The effect of hypertonicity on nasal mucociliary clearance. Clin Otolaryngol Allied Sci. 2000;25(6):558–60.

    Article  CAS  PubMed  Google Scholar 

  26. •• King D, Mitchell B, Williams CP, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015;4:CD006821. A systematic review of the effects of saline nasal irrigation for treating the symptoms of acute upper respiratory tract infections. With meta-analyses, the group assessed which patient population (adult or pediatric) and which symptoms had benefit from saline nasal irrigation.

    Google Scholar 

  27. Adam P, Stiffman M, Blake RL Jr. A clinical trial of hypertonic saline nasal spray in subjects with the common cold or rhinosinusitis. Arch Fam Med. 1998;7(1):39–43.

    Article  CAS  PubMed  Google Scholar 

  28. Bollag U, Albrecht E, Wingert W. Medicated versus saline nose drops in the management of upper respiratory infection. Helvetica Paediatrica Acta. 1984;39(4):341–5.

    CAS  PubMed  Google Scholar 

  29. Wang YH, Ku MS, Sun HL, Lue KH. Efficacy of nasal irrigation in the treatment of acute sinusitis in atopic children. J Microbiol Immunol Infect. 2014;47(1):63–9.

    Article  PubMed  Google Scholar 

  30. •• Chong LY, Head K, Hopkins C, Philpott C, Glew S, Scadding G, et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016;4:CD011995. A systematic review of the effects of saline nasal irrigation for treating chronic rhinosinusitis. The group assessed benefit of large-volume nasal saline irrigation separately from low-volume nebulized saline.

    PubMed  Google Scholar 

  31. Harvey R, Hannan SA, Badia L, Scadding G. Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev. 2007;3:CD006394.

    Google Scholar 

  32. Bachmann G, Hommel G, Michel O. Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch ORL. 2000;257(10):537–41.

    CAS  Google Scholar 

  33. Shoseyov D, Bibi H, Shai P, Shoseyov N, Shazberg G, Hurvitz H. Treatment with hypertonic saline versus normal saline nasal wash of pediatric chronic sinusitis. J Allergy Clin Immunol. 1998;101(5):602–5.

    Article  CAS  PubMed  Google Scholar 

  34. Cassandro E, Chiarella G, Cavaliere M, Sequino G, Cassandro C, Prasad SC, et al. Hyaluronan in the treatment of chronic rhinosinusitis with nasal polyposis. Ind J Otolaryngol Head Neck Surg. 2015;67(3):299–307.

    Article  Google Scholar 

  35. Heatley DG, McConnell KE, Kille TL, Leverson GE. Nasal irrigation for the alleviation of sinonasal symptoms. Otolaryngol Head Neck Surg. 2001;125(1):44–8.

    Article  CAS  PubMed  Google Scholar 

  36. Rabago D, Zgierska A, Mundt M, Barrett B, Bobula J, Maberry R. Efficacy of daily hypertonic saline nasal irrigation among patients with sinusitis: a randomized controlled trial. Fam Pract. 2002;51(12):1049–55.

    Google Scholar 

  37. Leonard DW, Bolger WE. Topical antibiotics therapy for recalcitrant sinusitis. Laryngoscope. 1999;109(4):668–70.

    Article  CAS  PubMed  Google Scholar 

  38. Vaughan WC, Carvalho G. Use of nebulized antibiotics for acute infections in chronic sinusitis. Otolaryngol Head Neck Surg. 2002;127(6):558–68.

    Article  PubMed  Google Scholar 

  39. Neher A, Fischer H, Appenroth E, Lass-Florl C, Mayr A, Gschwendtner A, et al. Tolerability of N-chlorotaurine in chronic rhinosinusitis applied via yamik catheter. Auris Nasus Larynx. 2005;32(4):359–64.

    Article  PubMed  Google Scholar 

  40. Solares CA, Batra PS, Hall GS, Citardi MJ. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations. Am J Otolaryngol. 2006;27(3):161–5.

    Article  CAS  PubMed  Google Scholar 

  41. Kamijyo A, Matsuzaki Z, Kikushima K, Ogino J, Nozawa I, Matsuoka T, et al. Fosfomycin nebulizer therapy to chronic sinusitis. Auris Nasus Larynx. 2001;28(3):227–32.

    Article  CAS  PubMed  Google Scholar 

  42. Scheinberg PA, Otsuji A. Nebulized antibiotics for the treatment of acute exacerbations of chronic rhinosinusitis. Ear Nose Throat J. 2002;81(9):648–52.

    PubMed  Google Scholar 

  43. Lee VS, Davis GE. Culture-directed topical antibiotics treatment for chronic rhinosinusitis. Am J Rhinol Allergy. 2016;30(6):414–7.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kobayashi T, Baba S. Topical use of antibiotics for paranasal sinusitis. Rhinology Suppl. 1992;14:77–81.

    CAS  Google Scholar 

  45. Lim M, Citardi MJ, Leong JL. Topical antimicrobials in the management of chronic rhinosinusitis: a systematic review. Am J Rhinol Allergy. 2008;22(4):381–9.

    Article  Google Scholar 

  46. Sykes DA, Wilson R, Chan KL, Mackay IS, Cole PJ. Relative importance of antibiotics and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet. 1986;2(8503):359–60.

    Article  CAS  PubMed  Google Scholar 

  47. Desrosiers MY, Salas-Prato M. Treatment of chronic rhinosinusitis refractory to other treatments with topical antibiotics therapy delivered by means of a large-particle nebulizer: results of a controlled trial. Otolaryngol Head Neck Surg. 2001;125(3):265–9.

    Article  CAS  PubMed  Google Scholar 

  48. Videler WJ, van Drunen CM, Reitsma JB, Fokkens WJ. Nebulized bacitracin/colimycin: a treatment option in recalcitrant chronic rhinosinusitis with Staphylococcus aureus? A double-blind, randomized, placebo-controlled, cross-over pilot study. Rhinology. 2008;46(2):92–8.

    CAS  PubMed  Google Scholar 

  49. Wei JL, Sykes KJ, Johnson P, He J, Mayo MS. Safety and efficacy of once-daily nasal irrigation for the treatment of pediatric chronic rhinosinusitis. Laryngoscope. 2011;121(9):1989–2000.

    PubMed  Google Scholar 

  50. Jervis-Bardy J, Boase S, Psaltis A, Foreman A, Wormald PJ. A randomized trial of mupirocin sinonasal rinses versus saline in surgically recalcitrant staphylococcal chronic rhinosinusitis. Laryngoscope. 2012;122(10):2148–53.

    Article  CAS  PubMed  Google Scholar 

  51. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clinic Proc. 1999;74(9):877–84.

    Article  CAS  Google Scholar 

  52. Lackner A, Stammberger H, Buzina W, Freudenschuss K, Panzitt T, Schosteritsch S, et al. Fungi: a normal content of human nasal mucus. Am J Rhinol Allergy. 2005;19(2):125–9.

    Google Scholar 

  53. Sacks PL, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst rev. 2011;8:CD008263.

    Google Scholar 

  54. Sacks PL, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis. Am J Rhinol Allergy. 2012;26(2):141–7.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, et al. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006;118(5):1149–56.

    Article  CAS  PubMed  Google Scholar 

  56. Gerlinger I, Fittler A, Fonai F, Patzko A, Mayer A, Botz L. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch ORL. 2009;266(6):847–55.

    CAS  Google Scholar 

  57. Liang KL, Su MC, Shiao JY, Tseng HC, Hsin CH, Lin JF, et al. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study. Am J Rhinol Allergy. 2008;22(1):52–8.

    Article  Google Scholar 

  58. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005;115(1):125–31.

    Article  CAS  PubMed  Google Scholar 

  59. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004;113(6):1122–8.

    Article  CAS  PubMed  Google Scholar 

  60. Wang DY, Wardani RS, Singh K, Thanaviratananich S, Vicente G, Xu G, et al. A survey on the management of acute rhinosinusitis among Asian physicians. Rhinology. 2011;49(3):264–71.

    CAS  PubMed  Google Scholar 

  61. Passali D, Salerni L, Passali GC, Passali FM, Bellussi L. Nasal decongestants in the treatment of chronic nasal obstruction: efficacy and safety of use. Exp Opin Drug Saf. 2006;5(6):783–90.

    Article  CAS  Google Scholar 

  62. •• Kirtsreesakul V, Khanuengkitkong T, Ruttanaphol S. Does oxymetazoline increase the efficacy of nasal steroids in treating nasal polyposis? Am J Rhinol Allergy. 2016;30(3):195–200. A randomized placebo-controlled trial in patients with chronic rhinosinusitis with nasal polyps evaluating additive effects of oxymetazoline on intranasal steroids assessing nasal symptoms score, peak inspiratory flow index, nasal mucociliary clearance time, and total nasal polyps score. Any rebound congestion after oxymetazoline treatment was also analyzed.

    Article  PubMed  Google Scholar 

  63. Chiu AG, Palmer JN, Woodworth BA, Doghramji L, Cohen MB, Prince A, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol. 2008;22(1):34–7.

    Article  PubMed  Google Scholar 

  64. Valentine R, Jervis-Bardy J, Psaltis A, Tan LW, Wormald PJ. Efficacy of using a hydrodebrider and of citric acid/zwitterionic surfactant on a Staphylococcus aureus bacterial biofilm in the sheep model of rhinosinusitis. Am J Rhinol Allergy. 2011;25(5):323–6.

    Article  PubMed  Google Scholar 

  65. Farag AA, Deal AM, McKinney KA, Thorp BD, Senior BA, Ebert CS Jr, et al. Single-blind randomized controlled trial of surfactant vs hypertonic saline irrigation following endoscopic endonasal surgery. Int Forum Allergy Rhinol. 2013;3(4):276–80.

    Article  PubMed  Google Scholar 

  66. Tan NC, Cooksley CM, Paramasivan S, Vreugde S, Wormald PJ. Safety evaluation of a sinus surfactant in an explant-based cytotoxicity assay. Laryngoscope. 2014;124(2):369–72.

    Article  CAS  PubMed  Google Scholar 

  67. Chiu AG, Chen B, Palmer JN, O'Malley BW Jr, Cohen NA. Safety evaluation of sinus surfactant solution on respiratory cilia function. Int Forum Allergy Rhinol. 2011;1(4):280–3.

    Article  PubMed  Google Scholar 

  68. Isaacs S, Fakhri S, Luong A, Whited C, Citardi MJ. The effect of dilute baby shampoo on nasal mucociliary clearance in healthy subjects. Am J Rhinol Allergy. 2011;25(1):e27–9.

    Article  PubMed  Google Scholar 

  69. Beule A, Athanasiadis T, Athanasiadis E, Field J, Wormald PJ. Efficacy of different techniques of sinonasal irrigation after modified Lothrop procedure. Am J Rhinol Allergy. 2009;23(1):85–90.

    Article  PubMed  Google Scholar 

  70. Harvey RJ, Goddard JC, Wise SK, Schlosser RJ. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol Head Neck Surg. 2008;139(1):137–42.

    Article  PubMed  Google Scholar 

  71. Singhal D, Weitzel EK, Lin E, Feldt B, Kriete B, McMains KC, et al. Effect of head position and surgical dissection on sinus irrigant penetration in cadavers. Laryngoscope. 2010;120(12):2528–31.

    Article  PubMed  Google Scholar 

  72. Valentine R, Athanasiadis T, Thwin M, Singhal D, Weitzel EK, Wormald PJ. A prospective controlled trial of pulsed nasal nebulizer in maximally dissected cadavers. Am J Rhinol. 2008;22(4):390–4.

    Article  PubMed  Google Scholar 

  73. Snidvongs K, Chaowanapanja P, Aeumjaturapat S, Chusakul S, Praweswararat P. Does nasal irrigation enter paranasal sinuses in chronic rhinosinusitis? Am J Rhinol. 2008;22(5):483–6.

    Article  PubMed  Google Scholar 

  74. Grobler A, Weitzel EK, Buele A, Jardeleza C, Cheong YC, Field J, et al. Pre- and postoperative sinus penetration of nasal irrigation. Laryngoscope. 2008;118(11):2078–81.

    Article  PubMed  Google Scholar 

  75. Merkus P, Ebbens FA, Muller B, Fokkens WJ. The ‘best method’ of topical nasal drug delivery: comparison of seven techniques. Rhinology. 2006;44(2):102–7.

    CAS  PubMed  Google Scholar 

  76. Hwang PH, Woo RJ, Fong KJ. Intranasal deposition of nebulized saline: a radionuclide distribution study. Am J Rhinol. 2006;20(3):255–61.

    Article  PubMed  Google Scholar 

  77. Negley JE, Krause H, Pawar S, Reeves-Hoche MK. RinoFlow nasal wash and sinus system as a mechanism to deliver medications to the paranasal sinuses: results of a radiolabeled pilot study. Ear Nose Throat J. 1999;78(8):550–2. 3-4

    CAS  PubMed  Google Scholar 

  78. Olson DE, Rasgon BM, Hilsinger RL Jr. Radiographic comparison of three methods for nasal saline irrigation. Laryngoscope. 2002;112(8 Pt 1):1394–8.

    Article  PubMed  Google Scholar 

  79. Wormald PJ, Cain T, Oates L, Hawke L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004;114(12):2224–7.

    Article  PubMed  Google Scholar 

  80. Miller TR, Muntz HR, Gilbert ME, Orlandi RR. Comparison of topical medication delivery systems after sinus surgery. Laryngoscope. 2004;114(2):201–4.

    Article  PubMed  Google Scholar 

  81. Pynnonen MA, Mukerji SS, Kim HM, Adams ME, Terrell JE. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg. 2007;133(11):1115–20.

    Article  PubMed  Google Scholar 

  82. • Neubauer PD, Schwam ZG, Manes RP. Comparison of intranasal fluticasone spray, budesonide atomizer, and budesonide respules in patients with chronic rhinosinusitis with polyposis after endoscopic sinus surgery. Int Forum Allergy Rhinol. 2016;6(3):233–7. A randomized controlled trial in patients with chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery evaluating the effects of intranasal steroid when administered by three different devices. The group compared fluticasone nasal spray with budesonide respules via a mucosal atomization device and budesonide respules instilled via the vertex-to-floor while in the real practice off-label intranasal steroids are increasingly used other than traditional intranasal steroids.

    Article  PubMed  Google Scholar 

  83. • Harvey RJ, Kalish L, Oakley GM, Christensen JM, Snidvongs K, Sacks R. Irrigation based corticosteroids therapy is more effective than simple sprays in managing post-surgical chronic rhinosinusitis. American Rhinologic Society 2016 annual meeting San Diego, California, United States 2016. p. 30. A randomized controlled trial in patients with chronic rhinosinusitis with and without nasal polyps after endoscopic sinus surgery evaluating the effects of a mometasone 2 mg dose delivered in either a 240 ml nasal irrigation solution or as 0.2 ml nasal spray once a day. All patients used both spray and irrigation with the active agent in one and placebo in the other.

  84. • Snidvongs K, Kalish L, Sacks R, Sivasubramaniam R, Cope D, Harvey RJ. Sinus surgery and delivery method influence the effectiveness of topical corticosteroids for chronic rhinosinusitis: systematic review and meta-analysis. Am J Rhinol Allergy. 2013;27(3):221–33. A review of the influence of sinus surgery and delivery methods on the effectiveness of intranasl steroids for chronic rhinosinusitis with meta-analyses. The application of corticosteroid to the nose does not always imply sinus delivery. The surgical state of the sinuses and the method or device used has been shown to heavily influence delivery to the sinus mucosa by this review.

    Article  PubMed  PubMed Central  Google Scholar 

  85. Aoki FY, Crowley JC. Distribution and removal of human serum albumin-technetium 99m instilled intranasally. Br J Clin Pharmacol. 1976;3(5):869–78.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  86. Kayarkar R, Clifton NJ, Woolford TJ. An evaluation of the best head position for instillation of steroids nose drops. Clin Otolaryngol Allied Sci. 2002;27(1):18–21.

    Article  CAS  PubMed  Google Scholar 

  87. Moren F, Bjornek K, Klint T, Wagner ZG. A comparative distribution study of two procedures for administration of nose drops. Acta Otolaryngol. 1988;106(3–4):286–90.

    Article  CAS  PubMed  Google Scholar 

  88. Kubba H, Spinou E, Robertson A. The effect of head position on the distribution of drops within the nose. Am J Rhinol. 2000;14(2):83–6.

    Article  CAS  PubMed  Google Scholar 

  89. Karagama YG, Lancaster JL, Karkanevatos A, O'Sullivan G. Delivery of nasal drops to the middle meatus: which is the best head position? Rhinology. 2001;39(4):226–9.

    CAS  PubMed  Google Scholar 

  90. Cannady SB, Batra PS, Citardi MJ, Lanza DC. Comparison of delivery of topical medications to the paranasal sinuses via “vertex-to-floor” position and atomizer spray after FESS. Otolaryngol Head Neck Surg. 2005;133(5):735–40.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand

    Kornkiat Snidvongs

  2. Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

    Sanguansak Thanaviratananich

Authors
  1. Kornkiat Snidvongs
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sanguansak Thanaviratananich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kornkiat Snidvongs.

Ethics declarations

Conflict of Interest

Drs. Snidvongs and Thanaviratananich have served as speakers for Merck Sharp & Dohme and GlaxoSmithKline. This is an unfunded project.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Rhinosinusitis

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Snidvongs, K., Thanaviratananich, S. Update on Intranasal Medications in Rhinosinusitis. Curr Allergy Asthma Rep 17, 47 (2017). https://doi.org/10.1007/s11882-017-0720-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11882-017-0720-3

Keywords

Search

Navigation